By recognizing CEA, a well-characterized CRC biomarker localized on the cell membrane, the designed CEABP1 protein enhanced the delivery selectivity of p53 protein and TCF/LEF TFD DNA into CRC cells. This evidence concerns the gene TP53 and colorectal carcinoma.